M
MI Skin Innovations, LLC. | Northville, MI
Research site
Site insights
Top conditions
Top treatments
BFB759
EVO756
PF-07264660
Tirzepatide
Ixekizumab
PF-07275315
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Syed Rahman
Verified by this site
Active trials
3 of 5 total trials
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Enrolling
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Enrolling
Hidradenitis Suppurativa (HS)
Other: Placebo for BFB759
Biological: BFB759
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo
Trial sponsors
B
E
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems